Publication Name	World Journal of Hepatology
Manuscript ID	77773
Country	United States

Received	2022-05-19 17:15
Peer-Review Started	2022-05-19 17:19
To Make the First Decision
Return for Revision	2022-06-09 16:23
Revised	2022-06-22 18:38
Second Decision	2022-08-08 03:09
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2022-08-18 00:12
Articles in Press	2022-08-18 00:12
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-08-19 02:45
Publish the Manuscript Online	2022-09-23 00:48

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Therapies for non-alcoholic fatty liver disease: A 2022 update
Manuscript Source	Unsolicited Manuscript
All Author List	Katie Shen, Achintya D Singh, Jamak Modaresi Esfeh and Jamile Wakim-Fleming
ORCID	Author(s) ORCID Number Katie Shen http://orcid.org/0000-0003-1056-9703 Jamak Modaresi Esfeh http://orcid.org/0000-0002-9429-5465
Funding Agency and Grant Number
Corresponding Author	Katie Shen, MD, Doctor, Doctor, Department of Internal Medicine, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195, United States. shenk2@ccf.org
Key Words	Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Treatment
Core Tip	Non-alcoholic fatty liver disease (NAFLD) is a rapidly growing epidemic with high morbidity and mortality. Although lifestyle modifications will remain a cornerstone of disease management, a multitude of therapies are under development that target different aspects of NAFLD pathogenesis.
Publish Date	2022-09-23 00:48
Citation	Shen K, Singh AD, Modaresi Esfeh J, Wakim-Fleming J. Therapies for non-alcoholic fatty liver disease: A 2022 update. World J Hepatol 2022; 14(9): 1718-1729
URL	https://www.wjgnet.com/1948-5182/full/v14/i9/1718.htm
DOI	https://dx.doi.org/10.4254/wjh.v14.i9.1718

Full Article (PDF)	WJH-14-1718.pdf
Full Article (Word)	WJH-14-1718.docx
Manuscript File	77773_Auto_Edited-LJH-LS.docx
Answering Reviewers	77773-Answering reviewers.pdf
Audio Core Tip	77773-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	77773-Conflict-of-interest statement.pdf
Copyright License Agreement	77773-Copyright license agreement.pdf
Peer-review Report	77773-Peer-review(s).pdf
Scientific Misconduct Check	77773-Bing-Liu JH-2.jpg
Scientific Misconduct Check	77773-CrossCheck.jpg
Scientific Editor Work List	77773-Scientific editor work list.pdf
CrossCheck Report	77773-CrossCheck report.pdf